Tuesday, February 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Mixed Signals for NetScout Investors

Dieter Jaworski by Dieter Jaworski
October 26, 2025
in Analysis, Cyber Security, Insider Trading, Tech & Software
0
NetScout Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Investors in NetScout are facing a complex puzzle as major financial institutions and corporate insiders move in opposite directions. The stock concluded Friday’s trading session at $26.85, marking a 1.40 percent gain amid fluctuating prices throughout the day.

Corporate Insiders Reduce Holdings

While institutional players demonstrate confidence, a different story unfolds behind the scenes. Director Michael Szabados decreased his stake by 9.32 percent, while Alfred Grasso executed an even larger reduction of 14.61 percent. Collectively, insiders have disposed of shares worth $358,873 over the past three months, raising questions about their outlook for the network security company.

Heavyweight Investors Build Positions

The substantial institutional ownership of 91.64 percent underscores strong support from major investment firms. Recent regulatory filings reveal significant position building: Allspring Global Investments added 22,004 shares during the second quarter of 2025, while CWM LLC dramatically expanded its exposure with a 91.1 percent increase. These moves represent a powerful endorsement from sophisticated market participants.

Should investors sell immediately? Or is it worth buying NetScout?

Divided Analyst Outlook Ahead of Earnings

Market experts display considerable disagreement in their assessment of NetScout’s prospects. The consensus recommendation currently stands at “Hold” with a $29 price target, yet individual firms present contrasting views. B. Riley maintains a “Buy” rating with a more optimistic $33 target, while Weiss Ratings advocates selling the security.

All eyes now turn to the company’s quarterly results scheduled for November 6. The upcoming financial report will reveal whether the institutional buyers or the departing insiders made the wiser strategic decision.

Ad

NetScout Stock: Buy or Sell?! New NetScout Analysis from February 3 delivers the answer:

The latest NetScout figures speak for themselves: Urgent action needed for NetScout investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.

NetScout: Buy or sell? Read more here...

Tags: NetScout
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Xiaomi Stock
Analysis

Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads

February 3, 2026
Apple Stock
Earnings

Apple Shares Surge on Stellar Quarterly Performance

February 3, 2026
Micron Stock
AI & Quantum Computing

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

February 2, 2026
Next Post
Caleres Stock

Caleres Shares Face Mounting Pressure as Analyst Concerns Deepen

Workiva Stock

Workiva Shares: Conflicting Signals Create Investor Dilemma

Arbor Realty Stock

Critical Earnings Report Looms for Arbor Realty Trust

Recommended

Biotechnology Markets and money

Ginkgo Bioworks Acquires Reverie Labs Assets in Groundbreaking Biotech and AI Integration Deal

2 years ago
Salesforce Stock

Salesforce’s Defining Moment Approaches as Quarterly Results Loom

2 months ago
Applovin Stock

Applovin Stock: Institutional Buying Clashes With Major Insider Selling

5 months ago
Technology Quantum computing Market Capitalization

The Importance of Innovation for Business Growth and Value Generation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Barrick Gold Investors Brace for a Pivotal Week

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

Uranium Energy’s Strategic Position Strengthens Amid US Nuclear Push

Regulatory Showdown in Washington Weighs on Coinbase Shares

Fintechwerx Advances AI Integration with New Platform Development

Realty Income Charts a New Course with Strategic GIC Alliance

Trending

Unitedhealth Stock
Earnings

UnitedHealth Faces Investor Backlash Over Regulatory Proposal

by Felix Baarz
February 3, 2026
0

Shares of UnitedHealth Group came under significant pressure this week following a regulatory announcement that fell dramatically...

Xiaomi Stock

Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads

February 3, 2026
Apple Stock

Apple Shares Surge on Stellar Quarterly Performance

February 3, 2026
Barrick Stock

Barrick Gold Investors Brace for a Pivotal Week

February 3, 2026
Micron Stock

Micron Technology Shares Surge to Unprecedented Heights on AI Demand

February 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Faces Investor Backlash Over Regulatory Proposal
  • Xiaomi’s Dual Challenge: Smartphones and Electric Vehicles at a Crossroads
  • Apple Shares Surge on Stellar Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com